Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Stock to Sell Today: HDFC Securities cautious on Nykaa – 5 reasons why – Markets

Stock to Sell Today: HDFC Securities cautious on Nykaa – 5 reasons why (Image: Canva/ET Now Digital) Stock to Sell Today: FSN E-Commerce Ventures Limited, popularly known as Nykaa, is a prominent Indian consumer technology platform. It is one of the market leaders in content-led, lifestyle retail. The company operates primarily through Nykaa Beauty and…

Read More
UGC NET June 2026 re-exam scheduled for affected candidates at this centre; check details here

UGC NET June 2026 re-exam scheduled for affected candidates at this centre; check details here

NTA schedules UGC NET re-test after technical issues at Jalandhar examination centre UGC NET June 2026 re-exam: The National Testing Agency (NTA) has announced a re-examination for a section of candidates affected by technical issues during the UGC NET June 2026 examination at the CT Group of Institutions Examination Centre in Jalandhar. The disruption was…

Read More
Anne Hathaway focuses on family, says 'We're all just in it' as she awaits baby No. 3 |

Anne Hathaway focuses on family, says ‘We’re all just in it’ as she awaits baby No. 3 |

The actress revealed she is expecting her third baby with husband Adam Shulman, sharing the joyful news in a heartfelt social media post.image credit (Anne Hathaway instagram) Anne Hathaway is preparing to welcome her third child while maintaining her focus on family and professional endeavours. The 43-year-old actress, who is expecting her third baby with…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Aurobindo Pharma Share In Focus: Nuvama hikes target for pharma stock after $250 mn Lannett buyout nod – Key reasons to Buy – Markets

Aurobindo Pharma Share In Focus: Nuvama hikes target for pharma stock after $250 mn Lannett buyout nod – Key reasons to Buy (Image source: Shutterstock/ET NOW) Aurobindo Pharma Share Price Target 2026: Brokerage firm Nuvama has delivered a bullish outlook on Aurobindo Pharma’s stock after the company said its arm Aurobindo Pharma USA, Inc had…

Read More